NYSE: EGEverest Group Ltd Stock
$359.29+4.26 (+1.2%)
Updated Apr 29, 2025
EG Price
$359.29
Fair Value Price
N/A
Market Cap
$15.43B
52 Week Low
$320.00
52 Week High
$407.30
P/E
11.31x
P/B
1.11x
P/S
0.9x
PEG
0.32x
Dividend Yield
2.23%
Revenue
$17.28B
Earnings
$1.37B
Gross Margin
15.5%
Operating Margin
9.5%
Profit Margin
7.9%
Debt to Equity
3.06
Operating Cash Flow
$5B
Beta
0.68
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
EG Overview
Everest Re Group, Ltd. offers reinsurance and insurance products in the U.S. and internationally. Its Reinsurance Operations segment writes property and casualty reinsurance, and specialty lines of business through reinsurance brokers. The Insurance Operations segment writes property and casualty insurance directly, as well as through brokers, surplus lines brokers, and general agents. Everest Re Group was founded in 1973 and is headquartered in Hamilton, Bermuda.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EG's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Reinsurance Insurance
Industry Rating
D
EG
Ranked#2 of 8
Ranked#2 of 8
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $53.45 | C | |
| $13.23 | C | |
| $17.02 | C |
Be the first to know about important EG news, forecast changes, insider trades & much more!
EG News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EG ($359.29) is trading below its intrinsic value of $574.22, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EG is good value based on its earnings relative to its share price (11.31x), compared to the US market average (29.19x)
P/E vs Market Valuation
EG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more EG due diligence checks available for Premium users.
Valuation
EG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.31x
Industry
10.75x
Market
29.19x
EG is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EG is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
EG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.11x
Industry
1.11x
EG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EG price to earnings growth (PEG)
For valuing profitable companies with growth potential
EG is good value based... subscribe to Premium to read more.
PEG Value Valuation
EG's financial health
Profit margin
Revenue
$4.6B
Net Income
-$593.0M
Profit Margin
-12.8%
EG's Earnings (EBIT) of $1.64B... subscribe to Premium to read more.
Interest Coverage Financials
EG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$56.3B
Liabilities
$42.5B
Debt to equity
3.06
EG's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
EG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$780.0M
Investing
-$933.0M
Financing
$112.0M
EG's operating cash flow ($4.96B)... subscribe to Premium to read more.
Debt Coverage Financials
EG vs Reinsurance Insurance Stocks
Everest Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.